Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1436]

Cancer medicine shortages for children around the world

Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis...

Cancer medicine shortages for children around the world ( Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA )

Silver linings: a qualitative study of desirable changes to cancer care during...

Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe...

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic ( Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand )

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first...

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )

Clinical utility of molecular tumour profiling in breast cancer

Prof Fabrice André - Gustave Roussy, Paris, France

Clinical utility of molecular tumour profiling in breast cancer ( Prof Fabrice André - Gustave Roussy, Paris, France )

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail...

Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma. ( Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy )

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative...

Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients ( Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA )

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in...

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA

$Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )$

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma ( Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA )

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace...

Latest in advanced endometrial cancer ( Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote )

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )

Latest in diagnostics in EGFR mutated NSCLC

Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA

Latest in diagnostics in EGFR mutated NSCLC ( Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA )

More from ecancer